To confirm that cancer cell-derived lactate stimulated CCL5 production, MDA-MB-231 cells were pre-treated with 15μM GSK 2837808A (a selective LDHA inhibitor [18]) for 2 h, and the conditional medium (MD-231 CM) were then collected and applied to THP-1 macrophages. This evidence concerns the gene CCL5 and cancer.